AzTrials
AzTrials

ExerciseNCT03131804

Effect of Intradialytic Exercise In The United Arab Emirates

A study testing Intradialytic aerobic low intensity exercise in people with Exercise and Dialysis, run by Zayed University at 1 site in United Arab Emirates.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hemodialysis (HD) patients have decreased physical functioning, diminished muscle mass and altered muscle quality thus the increased mortality rate compared to their age-matched population. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Exercise, Dialysis
What is being tested?
Intradialytic aerobic low intensity exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
41 participants
Where
1 siteUnited Arab Emirates
Study dates
1 Mar 2017to 1 Apr 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • HD patients from the selected HD units in the UAE on HD 3 times a week
  • Stable on HD (free of life -threatening acute or chronic disease, with a life expectancy of > 6 months)
  • ≥ 3 months on HD
  • The gender being irrespective (age ≥ 18)
  • Not practicing any physical activity
  • With no recent hospitalization (in the last 3 months for ACUTE condition)
Show all 10Show fewer
  • At their full capacity of cognitive, psychiatric and physical ability for self-care and communication
  • Capable to communicate either verbally or through writing
  • Fully aware of the proposed protocol of the study, and able to provide a consent form.
  • All selected patients should have received clearance from their nephrologist and cardiologist that they are eligible to start an exercise program

Who cannot join

  • Patients not meeting the inclusion criteria listed above
  • Patients not able to perform the exercise program
  • Patients who did not receive the clearance of the attending nephrologist of the unit to participate in the study

Trial locations and contacts

1 site in 1 country.

United Arab Emirates1 site
  • AL Qassimi Hospital

    Sharjah city, 3500

Other trials in United Arab Emirates

About this study

Official title: Effect of Intradialytic Exercise Among Hemodialysis Patients in the United Arab Emirates on Cardio-Metabolic Markers, Dialysis Adequacy, Quality of Life and Cost Effectiveness

Hemodialysis (HD) patients have decreased physical functioning, diminished muscle mass and altered muscle quality thus the increased mortality rate compared to their age-matched population. Risk factors include their sedentary lifestyle and altered nutritional status [1]; the sedentary lifestyle or the lack of exercise is known to be a risk factor for cardiovascular complications [2] and contributes to worsen protein energy wasting (PEW), which is described as the loss of body protein mass and fuel reserves [1]. Therefore the health of the HD patients and consequently their quality of life (QOL) is deteriorated.

Studies have shown that aerobic exercise during HD improves aerobic capacity, blood pressure, heart rate, muscular strength, dialysis efficacy and quality of life; however, such studies were not done on the United Arab Emirates (UAE) HD patients and there is no protocol for implementing exercise in the UAE HD units [3-4]

Read more

Hypothesis: Intradialytic aerobic exercise will result in significantly improved clinical, cardio-metabolic and quality of life outcomes and reduced cost of care.

Primary objective of the study:

  • To investigate whether the intradialytic exercise (IDE) within the routine practice of hemodialysis in the UAE will improve adequacy of dialysis.

Secondary objectives of the study:

  • To study the effect of clinical and cardio-metabolic outcomes of the HD patients.
  • Explore whether the trial would improve the cost effectiveness of this patient population's health care
  • Define the nature of the IDE programs (intensity, duration, modality), and feasibility of its application in routine setting.

Importance of this research:

  • Pioneering research in the Middle East and Gulf Cooperation Council (GCC) countries where the effect of intradialytic exercise will be studied for the first time on Arab population.
  • It will contribute in identifying the exact strategies to integrate within the hemodialysis unit to improve clinical and cardio-metabolic outcomes, quality of life and healthcare cost.

Usefulness of this research to the UAE

  • It will improve the health care cost and reduce cost wastage in the UAE (lean management).
  • It will put UAE on the pedestal in front of other countries in integrating innovative methods for a better care of hemodialysis patients.
Read the detailed description

Each patient will be asked to follow an Intradialytic aerobic low intensity exercise program of 45 minutes per each HD session throughout the 6-month study duration. The exercise will be tailored to each HD patient's ability (measured by VO2Max), supervised by the hospital physiotherapist and the research team. Continuous support and encouragement to the patients will be provided to assure they complete the 45 minutes of exercise on each HD session. Additionally, patients will be educated on the health benefits of exercise and how to integrate safe exercise into their daily life (by the research assistants).

Research assistants will be trained by the principal investigator (PI) on the study instruments and data collection methods. These assistants will administer 4 questionnaires (5 minutes each) for each HD patient separately and will collect data from the medical chart of each patient. The assessment will take place during the HD session.

The research assistants will also collect from the patient's file blood test results on a monthly basis (relevant to the study mentioned in table1); additional needed parameters will be analysed from the same blood sample that the hospital already collect for the patients monitoring, and will be analysed by the hospital for a fee from the research fund. For the β-aminoisobutyric acid (BAIBA) tests - cardiometabolic marker, 5 ML of the blood sample from each patient will be transported to a specialized lab for analysis.

All of the parameters, except the demographics (collected only at t0), will be collected and monitored at 3 time points: Baseline (t0), post-intervention (t1) and follow up (t2).

Assessment tools include

  • Demographics: Height - Weight - Age - Social and Work status - Comorbidities - Education level
  • Biochemical markers: C-reactive protein, Urea reduction ration, Phosphorus (P), BAIBA, Vitamin D3, Parathyroid Hormone, Calcium and Phosphorus Product
  • Number of hospitalization days and emergency HD sessions
  • Exercise Behavior questionnaire consists of 7 questions to assess the activity level of the patient before implementing the program. It will reflect the patient's activity level and importance.
  • Barriers to physical activity questionnaire [5], which includes questions related to different categories of disease- and patient- specific barriers to physical activity (psychological, physical, and economical barriers) in addition to the lack of time factor.
  • Malnutrition Inflammation Score (MIS) [6]: This is a comprehensive scoring system with significant associations with prospective hospitalization and mortality as well as measures of nutrition, inflammation, and anemia in HD. MIS has 10 components, each with four levels of severity from 0 (normal) to 3 (severely abnormal). The sum of all 10 MIS components ranges from 0 (normal) to 30 (severely abnormal); a higher score reflects more severe degree of malnutrition and inflammation. The scoring sheet consists of four sections.
  • Quality of life (QOL) measured using the EuroQOL -5 health questionnaire [7]. It assesses 5 health concepts: mobility, self-care, usual activities (work, study, housework, and family or leisure activities), pain / discomfort, and anxiety / depression. Patients have 5 choices for each question to choose from to describe their health today. In addition, patients have to indicate on a scale marked from 0-100 their opinion about how good or bad their health state is today.
  • Exercise effort test: Heart rate monitoring to assess the level of exercise performed [8]
  • Exercise Fitness Level: measure using the Borg Scale of perceived Exertion [9]

All questionnaires that are originally not Arabic, will be translated to Arabic (local language), prior to study by 2 translators whose first language is Arabic. Next step, each questionnaire will be translated back to English by a dietitian whose first language is English and who also knows Arabic. All questionnaires will be validated by running them on 10 patients and accordingly modifying their feasibility to the Emirates HD patient's culture, language level and comprehension status.

The physiotherapist and the research assistants will be responsible for training the patients on the exercise program and recording the intensity, duration, and modality of the exercise for each patient as well as patient's complaints and reasons for drop out, if any. The intervention will be given within the HD session: no extra time required beyond the time of HD. During the intervention, patient will be at all times under direct supervision of the physiotherapist and medical team; in case of any discomfort, the intervention will be immediately stopped.

Sample size was chosen based on convenient sampling. Patients of the HD unit who received clearance from the medical team, met the inclusion criteria and consented, were included in the study.

Data will be analyzed through Scientific Package for Social Sciences version 18. Descriptive statistics will be used to analyze the data. Correlations will be conducted through ANOVA. Effect of the study will be analyzed by paired t test on continuous data and Chi-square on categorical data

Conditions
Exercise, Dialysis
Being tested
Intradialytic aerobic low intensity exercise
Keywords
Aerobic, Intradialytic, Cardio-metabolic markers, Dialysis Adequacy, Quality of Life, Cost Effectiveness
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Intradialytic aerobic low intensity exerciseOther

    Intradialytic aerobic low intensity exercise program of 45 minutes per each hemodialysis session throughout the 6-month study duration

Study groups in NCT03131804
Study groupRoleWhat they receive
Interventional ParticipantsExperimentalPatients will represent their own controls (pre and post intervention), in the HD unit of Al Qassimi Hospital, Sharjah, United Arab Emirates.
Receives: Other: Intradialytic aerobic low intensity exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Urea Reduction Ratio (URR) (mmol/L)

    it is blood urea nitrogen taken pre and post a dialysis session

    Measured: Baseline (average of the last 6 months), Week #9,14,18,22,27,31, and at 1 year post intervention

Secondary outcomes (6)
  1. Exercise Behavior questionnaire

    questionnaire

    Measured: at baseline, end of 6 month intervention, and at 1 year post intervention

  2. Quality of Life

    EQ-5D-5L questionnaire

    Measured: at baseline, end of 6 month intervention, and at 1 year

  3. Malnutrition- Inflammation Syndrome

    questionnaire

    Measured: at baseline, end of 6 month intervention, and at 1 year post intervention

  4. Exercise Fitness Level

    assessed through both the BORG scale (exertion level measurement) and heart rate (pulse per minute)

    Measured: Week #1,9,14,18,22,27,31

  5. Serum Phosphorous (mmol/L)

    Blood test

    Measured: Baseline (average of the past 6 months), Week #9,14,18,22,27,31, and at 1 year post intervention

  6. β-aminoisobutyric acid (μM)

    Blood test

    Measured: at baseline and at post 6 month intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Apr 2017
  2. Study start1 Mar 2017
  3. Primary completion1 Oct 2017
  4. Study completion1 Apr 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
41 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03131804
Sponsor's protocol ID
9637
Status last verified
Jun 2018
First submitted
17 Apr 2017
Last updated
26 Jun 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Magnard J, Deschamps T, Cornu C, Paris A, Hristea D. Effects of a six-month intradialytic physical ACTIvity program and adequate NUTritional support on protein-energy wasting, physical functioning and quality of life in chronic hemodialysis patients: ACTINUT study protocol for a randomised controlled trial. BMC Nephrol. 2013 Nov 26;14:259. doi: 10.1186/1471-2369-14-259.

    PubMed 24279747
  • Sheng K, Zhang P, Chen L, Cheng J, Wu C, Chen J. Intradialytic exercise in hemodialysis patients: a systematic review and meta-analysis. Am J Nephrol. 2014;40(5):478-90. doi: 10.1159/000368722. Epub 2014 Dec 9.

    PubMed 25504020
  • Heiwe S, Jacobson SH. Exercise training in adults with CKD: a systematic review and meta-analysis. Am J Kidney Dis. 2014 Sep;64(3):383-93. doi: 10.1053/j.ajkd.2014.03.020. Epub 2014 Jun 7.

    PubMed 24913219
  • Mohseni R, Emami Zeydi A, Ilali E, Adib-Hajbaghery M, Makhlough A. The effect of intradialytic aerobic exercise on dialysis efficacy in hemodialysis patients: a randomized controlled trial. Oman Med J. 2013 Sep;28(5):345-9. doi: 10.5001/omj.2013.99.

    PubMed 24044062
  • Fiaccadori E, Sabatino A, Schito F, Angella F, Malagoli M, Tucci M, Cupisti A, Capitanini A, Regolisti G. Barriers to physical activity in chronic hemodialysis patients: a single-center pilot study in an Italian dialysis facility. Kidney Blood Press Res. 2014;39(2-3):169-75. doi: 10.1159/000355793. Epub 2014 Jul 29.

    PubMed 25117942
  • Kalantar-Zadeh K, Kopple JD, Humphreys MH, Block G. Comparing outcome predictability of markers of malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrol Dial Transplant. 2004 Jun;19(6):1507-19. doi: 10.1093/ndt/gfh143. Epub 2004 Apr 6.

    PubMed 15069177
  • EuroQol Group. EuroQol--a new facility for the measurement of health-related quality of life. Health Policy. 1990 Dec;16(3):199-208. doi: 10.1016/0168-8510(90)90421-9.

    PubMed 10109801

Questions about this trial

What is this clinical trial studying?

A study testing Intradialytic aerobic low intensity exercise in people with Exercise and Dialysis, run by Zayed University at 1 site in United Arab Emirates.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jun 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Arab Emirates. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Urea Reduction Ratio (URR) (mmol/L) (time frame: Baseline (average of the last 6 months), Week #9,14,18,22,27,31, and at 1 year post intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03131804, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in